16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil [1]

Kunikazu Yamane; Flávia Rossi; Maria Goreth M.A. Barberino; Jennifer M. Adams-Haduch; Yohei Doi; David L. Paterson

doi:10.1093/jac/dkm526

16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil [1]

Kunikazu Yamane
, Flávia Rossi
, Maria Goreth M.A. Barberino
, Jennifer M. Adams-Haduch
, Yohei Doi
, David L. Paterson

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	746-747
Number of pages	2
Journal	Journal of Antimicrobial Chemotherapy
Volume	61
Issue number	3
DOIs	https://doi.org/10.1093/jac/dkm526
Publication status	Published - 03-2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Pharmacology
Microbiology (medical)
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1093/jac/dkm526

Cite this

@article{ca0f247f5182480e8eeab89aea7a8b04,

title = "16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil [1]",

keywords = "Aminoglycosides, Enterobacteriaceae, Ribosomal resistance",

author = "Kunikazu Yamane and Fl{\'a}via Rossi and Barberino, \{Maria Goreth M.A.\} and Adams-Haduch, \{Jennifer M.\} and Yohei Doi and Paterson, \{David L.\}",

note = "Funding Information: This study was supported by a grant to K. Y. from the Japan Health Sciences Foundation. F. R. has received research funding from Merck and Wyeth. Y. D. is supported in part by NIH training grant T32 AI007333. D. L. P. has received research funding from Pfizer, Elan, Merck and AstraZeneca and is supported in part by NIH research grant R01 AI070896.",

year = "2008",

month = mar,

doi = "10.1093/jac/dkm526",

language = "English",

volume = "61",

pages = "746--747",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - 16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil [1]

AU - Yamane, Kunikazu

AU - Rossi, Flávia

AU - Barberino, Maria Goreth M.A.

AU - Adams-Haduch, Jennifer M.

AU - Doi, Yohei

AU - Paterson, David L.

N1 - Funding Information: This study was supported by a grant to K. Y. from the Japan Health Sciences Foundation. F. R. has received research funding from Merck and Wyeth. Y. D. is supported in part by NIH training grant T32 AI007333. D. L. P. has received research funding from Pfizer, Elan, Merck and AstraZeneca and is supported in part by NIH research grant R01 AI070896.

PY - 2008/3

Y1 - 2008/3

KW - Aminoglycosides

KW - Enterobacteriaceae

KW - Ribosomal resistance

UR - https://www.scopus.com/pages/publications/40049112557

UR - https://www.scopus.com/pages/publications/40049112557#tab=citedBy

U2 - 10.1093/jac/dkm526

DO - 10.1093/jac/dkm526

M3 - Letter

C2 - 18222955

AN - SCOPUS:40049112557

SN - 0305-7453

VL - 61

SP - 746

EP - 747

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 3

ER -

16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil [1]

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this